Augmentation of neurally evoked cholinergic bronchoconstrictor responses by prejunctional NK2 receptors in the guinea-pig

Journal of Autonomic Pharmacology

Volumn 16, Issue 1, 1996, Pages 41-48

  Hey, J A ^a   Danko, G ^a   Del Prado, M ^a   Chapman, R W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; CAPSAICIN; METHACHOLINE; NEUROKININ 2 RECEPTOR; NEUROKININ A; NEUROKININ B; PHOSPHORAMIDON; PRESYNAPTIC RECEPTOR; SAREDUTANT; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BRONCHOSPASM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ELECTROSTIMULATION; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDULLA OBLONGATA; NONHUMAN;

EID: 0029896907     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.1996.tb00355.x     Document Type: Article

References (30)

1. ADVENIER, C., NALINE, E., DRAPEAU, G. & REGOLI, D. (1987). Relative potencies of neurokinins in guinea pig and human bronchi. Eur. J. Pharmacol., 139, 133-137.
2. AIZAWA, H., MIYAZAKI, N., INOUE, H., IKEDA, T. & SHIGEMATSU, N. (1990). Effect of endogenous tackykinins on neuro-effector transmission of vagal nerve in guinea pig tracheal tissue. Respiration, 57, 338-342.
3. BARNES, P.J. (1987). Airway neuropeptides and asthma. Trends Pharmacol. Sci., 8, 24-27.
4. BARNES, P.J. (1991). Neuropeptides and asthma. Am. Rev. Respir. Dis., 143, S28-S32.
5. BARNES, P.J., BARANUIK, J.N. & BELVISI, M.G. (1991). Neuropeptides in the respiratory tract. Am. Rev. Respir. Dis., 144, 1187-1198.
6. BELVISI, M.G., PATACCHINI, R., BARNES, P.J. & MAGGI, C.A. (1994). Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences. Br. J Pharmacol., 111, 103-110.
7. + channel blockade potentiates contraction to electrical stimulation in human bronchus. Eur. J. Pharmacol., 180, 311-317.
8. 35SO4-macromolecules from ferret trachea. Exp. Lung Res., 12, 21-36.
9. CHAPMAN, R.W., DANKO, G., DEL PRADO, M., EGAN, R.W., REUTNER, W., RIZZO, C.A. & HEY, J.A. (1993). Further evidence for prejunctional GABA-B inhibition of cholinergic and peptidergic bronchoconstriction in guinea pigs: studies with new agonists and antagonists. Pharmacol., 46, 315-323.
10. DANKO, G., HEY, J.A., DEL PRADO, M., KREUTNER, W. & CHAPMAN, R.W. (1992). GABA-B-induced inhibition of peptidergic airway microvascular leakage in guinea pigs. Pharmacol. Commun., 1, 203-209.
11. 2) receptor. Life Sci., 50, 101-106.
12. HALL, A.K., BARNES, P.J., MEDRUM, L.A. & MACLAGAN, J. (1989). Facilitation by tachykinins of neurotransmission in guinea-pig pulmonary parasympathetic nerves. Br. J. Pharmacol., 97, 274-280.
13. HEY, J.A., DEL PRADO, M. & CHAPMAN, R.W. (1990). Activation of a novel medullary pathway elicits a vagal, cholinergic bronchoconstriction in guinea pigs. Pulmon. Pharmacol., 3, 53-54.
14. HEY, J.A., DEL PRADO, M. & CHAPMAN, R.W. (1993). Central nervous system control of bronchomotor tone: pharmacological characterization of parasympathetic constrictor and sympathetic inhibitory responses in guinea pigs. J. Auton. Pharmacol., 13, 341-350.
15. HEY, J.A., DEL PRADO, M., EGAN, R.W., KREUTNER, W. & CHAPMAN, R. W. (1992). Involvement of sensory neuropeptides in the bronchospasm to nicotine in guinea pigs. Pharmacol. Commun., 2, 225-234.
16. HSUIE, T.-R., GARLAND, A., RAY, D.W., HERSHENSON, M.B., LEFF, A.R. & SOLWAY, J. (1992). Endogenous sensory neuropeptides release enhances nonspecific airway responsiveness in guinea pigs. Am. Rev. Respir. Dis., 146, 148-153.
17. JOHN, C., BRUNNER, S. & TANAKA, D.T. (1993). Neuromodulation mediated by neurokinin-1 subtype receptors in adult rabbit airways. Am. J. Physiol., 265, L228-L233.
18. MAGGI, C.A., PATACCHINI, R., ROVERO, P. & GIACHETTI, A. (1993). Tachykinin receptors and tachykinin receptor antagonists. J. Auton. Pharmacol., 13, 23-93.
19. MYERS, A.C. & UNDEM, B.J. (1991). Functional interactions between capsaicin-sensitive and cholinergic nerves in the guinea pig bronchus. J. Pharmacol. Exp. Ther., 259, 104-109.
20. OMINI, C., BRUNELLI, G., HERNANDEZ, A. & DAFFONCHIO, L. (1989). Bradykinm and substance P potentiate acetylcholine-induced bronchospasm in guinea pig. Eur. J. Pharmacol., 163, 195-197.
21. ROGERS, D.F., AURSUDKIJ, B. & BARNES, P.J. (1989). Effects of tachykinins on mucus secretion on human bronchi in vitro. Eur. J. Pharmacol., 174, 283-286.
22. ROGERS, D.F., BELVISI, M.G., AURSUDKIJ, B., EVANS, T.W. & BARNES, P.J. (1988). Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea pigs. Br. J. Pharmacol., 95, 1109-1116.
23. SARIA, A., MARTLING, C.R., YAN, Z., THEODORSSON-NORHEIM, E., GAMSE, R. & LUNDBERG, J.M. (1988). Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium and vagal nerve stimulation. Am. Rev. Respir. Dis., 137, 1330-1335.
24. SHORE, S.A. & DRAZEN, J.M. (1989a). Enhanced airway responses to substance P after repeated challenge in guinea pigs. J. Appl. Physiol., 62, 955-961.
25. SHORE, S.A. & DRAZEN, J.M. (1989b). Degradative enzymes modulate airway responses to intravenous neurokinins A and B. J. Appl. Physiol., 67, 2504-2511.
26. 1) receptor. Science, 25, 435-439.
27. STRETTON, D., BELVISI, M.G. & BARNES, P.J. (1992). The effect of sensory nerve depletion on cholinergic neurotransmission in guinea pig airways. J. Pharmacol. Exp. Ther., 260, 1073-1080.
28. THOMPSON, J.E. & SHEPPARD, D. (1988). Phosphoramidon potentiates the increase in lung resistance mediated by tachykinins in guinea pigs. Am. Rev. Respir. Dis., 137, 337-340.
29. UMENO, E., HIROSE, T. & NISHIMA, S. (1992). Pretreatment with aerosolized capsaicin potentiates histamine-induced brochoconstriction in guinea pigs. Am. Rev. Respir. Dis., 146, 159-162.
30. WATSON, N., MACLAGAN, J. & BARNES, P.J. (1993). Endogenous tachykinins facilitate transmission through parasympathetic ganglia in guinea pig trachea. Br. J. Pharmacol., 109, 751-759.